Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation
Launched by JOHNS HOPKINS UNIVERSITY · Mar 24, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people recover from strokes, especially those who have weakness on one side of their body (called hemiparesis). The study combines a low-cost robot device that helps with arm exercises and an online platform where participants can engage in activities with others. Researchers want to see how different social interactions—like competing or working together with others—affect recovery. They will measure how well participants improve in their rehabilitation exercises, how motivated they feel to take part, and how this process impacts their emotional well-being.
To be eligible for this study, participants must be at least 18 years old and have had a stroke more than three months ago. They should be able to sit or stand independently, have some movement in their affected arm, and be comfortable using online tools. People with certain visual problems, other serious health issues, or pain that limits their arm movement won’t be able to participate. Those who join can expect to engage in fun activities while working on their recovery, and their progress will be monitored by therapists. Overall, this trial aims to make rehabilitation more effective and enjoyable through innovative technology and community involvement.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For treatment group:
- • post-stroke hemiparesis \>3 months
- • ability to stand or sit independently
- • sufficient cognitive skills to perform the exercises as demonstrated
- • full passive range of motion in the affected arm but limited active movement as determined by a upper extremity Fugl-Meyer score of \<50/66
- • technical savvy and interest to use an internet platform
- For control group:
- • (ii) no history of learning disabilities (iii) technical savvy and interest to use an internet platform
- Exclusion Criteria:
- For treatment group:
- • visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect
- • medical comorbidity such as other neurological conditions (e.g. Parkinson's disease, brain tumor, epilepsy), or previous injury to the upper limb
- • pain in the upper limbs that prevents full passive range of motion to perform the exercises.
- For control group:
- • visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect
- • any previous injury or medical condition that prevents full passive range of motion to perform the exercises.
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Preeti Raghavan, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials